Sale!

VEGFA Gene Microvascular Complications of Diabetes Type 1 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The VEGFA Gene Microvascular Complications of Diabetes Type 1 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify individuals with Type 1 Diabetes who are at an increased risk of developing microvascular complications. These complications can include issues like diabetic retinopathy, nephropathy, and neuropathy, which are conditions affecting the small blood vessels and can lead to severe health problems if not managed properly.

The test specifically looks for variations in the VEGFA gene, which plays a crucial role in the formation of blood vessels and the regulation of vascular permeability. Alterations in this gene have been associated with an increased risk of developing microvascular complications among individuals with Type 1 Diabetes. By identifying these genetic predispositions early on, healthcare providers can tailor a patient’s treatment plan to manage their diabetes more effectively and take preventive measures to mitigate the risk of complications.

The cost of the test is 4400 AED, reflecting the comprehensive analysis and the detailed insights it provides into a patient’s genetic risk factors. Conducted at the state-of-the-art facilities of DNA Labs UAE, this genetic test represents a proactive approach to managing Type 1 Diabetes and its associated risks, enabling patients and healthcare professionals to work together towards achieving better health outcomes.

Description

VEGFA Gene Microvascular complications of diabetes type 1 Genetic Test

Components: VEGFA Gene Microvascular complications of diabetes type 1 Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Metabolic Disorders

Doctor: General Physician

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for VEGFA Gene Microvascular complications of diabetes type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Microvascular complications of diabetes type 1.

Test Details: The VEGFA gene is involved in the production of vascular endothelial growth factor A, which plays a critical role in angiogenesis (the formation of new blood vessels) and vascular permeability. Microvascular complications of diabetes type 1, such as diabetic retinopathy, diabetic nephropathy, and diabetic neuropathy, are known to be influenced by genetic factors. NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously, providing a comprehensive assessment of an individual’s genetic makeup. This type of testing can be used to identify variations or mutations in the VEGFA gene that may be associated with an increased risk of microvascular complications in individuals with type 1 diabetes. By identifying genetic variations in the VEGFA gene, NGS genetic testing can help in predicting an individual’s susceptibility to developing microvascular complications and may also assist in personalized treatment strategies. However, it is important to note that genetic testing is just one component of a comprehensive evaluation and should be interpreted in conjunction with clinical findings and other diagnostic tests.

Test Name	VEGFA Gene Microvascular complications of diabetes type 1 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Metabolic Disorders
Doctor	General Physician
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for VEGFA Gene Microvascular complications of diabetes type 1 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Microvascular complications of diabetes type 1
Test Details	The VEGFA gene is involved in the production of vascular endothelial growth factor A, which plays a critical role in angiogenesis (the formation of new blood vessels) and vascular permeability. Microvascular complications of diabetes type 1, such as diabetic retinopathy, diabetic nephropathy, and diabetic neuropathy, are known to be influenced by genetic factors. NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously, providing a comprehensive assessment of an individual’s genetic makeup. This type of testing can be used to identify variations or mutations in the VEGFA gene that may be associated with an increased risk of microvascular complications in individuals with type 1 diabetes. By identifying genetic variations in the VEGFA gene, NGS genetic testing can help in predicting an individual’s susceptibility to developing microvascular complications and may also assist in personalized treatment strategies. However, it is important to note that genetic testing is just one component of a comprehensive evaluation and should be interpreted in conjunction with clinical findings and other diagnostic tests.